| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-10 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-09 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |